United States · 
Who invested in MitoChem Therapeutics?
MitoChem Therapeutics's investors include South Carolina Research Authority and SC Launch.
United States · Venture startup
Who invested in MitoChem Therapeutics
Funding summaryUpdated 26 Oct 2026
$200Kraised across 1 round since 2022, from 1 source
- Latest round
- Venture, $200KSept 2022
- Investors
- 2
The rounds
- Sept 2022
Founders and team
From MitoChem Therapeutics's own website and the SEC filings it signed: 1 founder, 2 on the team.
Craig C Beeson PhDCo-Founder
- Michael VoevodskyPresident & CEO
- Dan AdamsBoard Director & Business Strategy
On the board, as filediBaerbel G. RohrerGyda Caren BeesonRick G. Schnellman
Everyone who backed them
SC LaunchVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about MitoChem Therapeutics
How much has MitoChem Therapeutics raised?
MitoChem Therapeutics has raised $200K across 1 round since 2022.
When did MitoChem Therapeutics last raise?
MitoChem Therapeutics's most recent round was a Venture of $200K in Sept 2022.
What was MitoChem Therapeutics's biggest round?
Its most recent round, $200K in Sept 2022, is also its largest on record.
Who backed MitoChem Therapeutics first?
MitoChem Therapeutics's first round on record, in Sept 2022, was backed by South Carolina Research Authority and SC Launch.
What stage is MitoChem Therapeutics at?
MitoChem Therapeutics's latest named round is a Venture, in Sept 2022.
Where is MitoChem Therapeutics based?
MitoChem Therapeutics is based in the United States.
Companies like MitoChem Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.